Advertisement
U.S. markets open in 1 hour 38 minutes
S&P Futures
5,970.50 +12.25 (+0.21%) Dow Futures
43,978.00 +77.00 (+0.18%) Nasdaq Futures
20,960.00 +66.00 (+0.32%) Russell 2000 Futures
2,418.80 +13.00 (+0.54%) Crude Oil
70.93 -0.76 (-1.06%) Gold
2,677.40 +1.10 (+0.04%)
Eloxx Pharmaceuticals, Inc. (ELOX)
OTC Markets EXMKT - OTC Markets EXMKT Delayed Price. Currency in USD
Follow
At close: 09:30AM EST
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 628.00 |
| Enterprise Value | 983.63k |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 6.31 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.10 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | -24.60 |
| 52-Week Change 3 | -99.98% |
| S&P500 52-Week Change 3 | 36.38% |
| 52 Week High 3 | 1.7400 |
| 52 Week Low 3 | 0.0001 |
| 50-Day Moving Average 3 | 0.0969 |
| 200-Day Moving Average 3 | 0.6346 |
Share Statistics
| Avg Vol (3 month) 3 | 4.09k |
| Avg Vol (10 day) 3 | 2.41k |
| Shares Outstanding 5 | 3.14M |
| Implied Shares Outstanding 6 | 3.15M |
| Float 8 | 2.59M |
| % Held by Insiders 1 | 5.98% |
| % Held by Institutions 1 | 19.59% |
| Shares Short (Sep 29, 2023) 4 | 21.48k |
| Short Ratio (Sep 29, 2023) 4 | 0.66 |
| Short % of Float (Sep 29, 2023) 4 | 0.80% |
| Short % of Shares Outstanding (Sep 29, 2023) 4 | 0.70% |
| Shares Short (prior month Aug 31, 2023) 4 | 33.78k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | Dec 20, 2017 |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:40 |
| Last Split Date 3 | Dec 02, 2022 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2022 |
| Most Recent Quarter (mrq) | Sep 30, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | 0.00% |
Management Effectiveness
| Return on Assets (ttm) | -73.24% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -19.24M |
| Net Income Avi to Common (ttm) | -20.48M |
| Diluted EPS (ttm) | -8.8800 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 4.78M |
| Total Cash Per Share (mrq) | 1.52 |
| Total Debt (mrq) | 18.72M |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.24 |
| Book Value Per Share (mrq) | -6.53 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -17.99M |
| Levered Free Cash Flow (ttm) | -8.25M |
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.